Clinical Trials Browser

Observational × Radiation Injuries × Genitourinary × Clear all

Urinary Bladder Neoplasms, Brain Neoplasms, Breast Neoplasms, Esophageal Neoplasms, Genital Neoplasms, Female, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Radiation Injuries, Rectal Neoplasms

NCT00769223 2025-03-20

Predicting the Risk of Failure in Patients Undergoing Radiation Therapy for Localized Prostate Cancer

Active not recruiting

3,561 enrolled

Genitourinary

Prostatic Neoplasms, Radiation Injuries

NCT05246774 2023-04-28

RABBIO

Unknown

60 enrolled

Genitourinary

Prostatic Neoplasms, Radiation Injuries

NCT04590976 2023-02-08

IP5-MATTER

Completed

320 enrolled

Genitourinary

Patient Acceptance of Health Care, Radiation Injuries, Urologic Neoplasms, Patient Satisfaction

NCT03961217 2019-05-28

Return to Work Among Cancer Survivors With Treatment-induced Survivorship Syndromes

Completed

2,135 enrolled

Genitourinary

Neoplasms, Prostatic Neoplasms, Radiation Injuries

NCT00122239 2016-03-16

A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck Cancers

Unknown

13 enrolled

BreastCNSGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Glioma, Head and Neck Neoplasms, Prostatic Neoplasms, Radiation Injuries

NCT00122265 2016-02-26

Exploring Genomic, Proteomic and Dosimetric Determinants of Late Toxicity After Three Dimensional Conformal Radiotherapy (RT) for Prostate Cancer

Terminated

83 enrolled

Genitourinary

Prostatic Neoplasms, Radiation Injuries

Clinical Trials

MOMENTUM

Predicting the Risk of Failure in Patients Undergoing Radiation Therapy for Localized Prostate Cancer

RABBIO

IP5-MATTER

Return to Work Among Cancer Survivors With Treatment-induced Survivorship Syndromes

A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck Cancers

Exploring Genomic, Proteomic and Dosimetric Determinants of Late Toxicity After Three Dimensional Conformal Radiotherapy (RT) for Prostate Cancer